A comprehensive protein expression analysis predicting chemoresistance of HNSCC cells revealed that increased total NOTCH1 expression was associated with sensitivity to cisplatin-based treatment [109]. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.